Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 501–600 of 806
Yang, J. W., Ham, D. S., Kim, H. W., Lee, S. G., Park, S. K., & Seo, S. K. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1768-8 · Cited by 12
Fillatreau, S., & Anderton, S. M. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.565 · Cited by 12
“150 Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33(2), 137–151 (1993). 151 Rodriguez M, Lennon VA, Benveniste EN,”
BackgroundMucosally Restricted Antigens as Novel Immunological Targets for Antitumor Therapy
Snook, A. E., Stafford, B. J., Eisenlohr, L. C., Rothstein, J. L., & Waldman, S. A. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.187 · Cited by 10
“Structural and functional independence of immunological responses in mucosae is reminiscent of immunologically privileged tissues, such as the anterior chamber of the eye, testis, ovaries, brain and pregnant uterus, wherein central immune responses rarely extend to these privileged compartments [58–60].”
BackgroundPineda-Rodriguez, B., Toscano-Tejeida, D., García, E., Rodríguez‐Barrera, R., Flores‐Romero, A., Castellanos-Canales, D., Gutiérrez‐Ospina, G., Castillo-Carvajal, L. C., Meléndez‐Herrera, E., & Ibarra, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188506 · Cited by 10
The Cornea Has “the Nerve” to Encourage Immune Rejection
Blanco, T., & Saban, D. R. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13238 · Cited by 10
“Furthermore, the cornea enjoys immune privilege status, which is a feature that permits spontaneous acceptance in approximately 50% of corneal allografts in certain mouse strain combinations (3).”
BackgroundAntigen-Presenting Cells in the Eye and Ocular Surface
Hamrah, P., & Dana, R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374203-2.00007-5 · Cited by 10
Radiofrequency Irradiation Mitigated UV-B-Induced Skin Pigmentation by Increasing Lymphangiogenesis
Kim, H. M., Oh, S., Byun, K.-A., Yang, J. Y., Sun, H. J., Kang, D., Son, K. H., & Byun, K. (2022) · Molecules · doi:10.3390/molecules27020454 · Cited by 12
“Since the eyes lack lymphatic vessels, tyrosinase expression would thus possibly be associated with ocular alymphacity and immune privilege, as well as melanin production [47,48].”
BackgroundNanotherapy for Neural Retinal Regeneration
Yu, C., Dong, L., Lv, Y., Shi, X., Zhang, R., Zhou, W., Wu, H., Li, H., Li, Y., Zhou, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202409854 · Cited by 13
Yin, J., Ma, X., Hu, L., & Ye, H. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101425 · Cited by 17
Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis
Choi, J. K., & Egwuagu, C. E. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1237-8_23 · Cited by 11
Toda, M., Ueno, M., Yamada, J., Hiraga, A., Asada, K., Hamuro, J., Sotozono, C., & Kinoshita, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-22522-4 · Cited by 9
Peng, P., Yu, Y., Ma, W., Lyu, S., Li, M., Liu, T., Dong, Y., & Wei, C. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109457 · Cited by 9
Evidence for Extrathymic Generation of Regulatory T Cells Specific for a Retinal Antigen
Gregerson, D. S., Heuss, N. D., Lehmann, U., & McPherson, S. W. (2008) · Ophthalmic Research · doi:10.1159/000119868 · Cited by 9
“It has been postulated that this induced regulatory response, i.e. ACAID, represents the activity of the endogenous, T-cell-mediated immunoregulatory activities of the eye, including the retina [”
The Trojan Horse Tale Revisited: An Eye on Metastatic Spread of Carcinoma Cells
Grajewski, R. S., Bosch, J. J., Bruns, H., Cursiefen, C., & Heindl, L. M. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0127 · Cited by 9
“Trojan horse to enter the immune-privileged eye (12) to find a new environment for further tumor growth and metastasis.”
BackgroundPluripotent stem cells as models of retina development
Lu, A. Q., & Barnstable, C. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1504-7 · Cited by 10
Wen, H., Gallo, R. A., Huang, X., Cai, J., Mei, S., Farooqı, A. A., Zhao, J., & Tao, W. (2021) · Journal of Ophthalmology · doi:10.1155/2021/5580595 · Cited by 12
“Corneas are generally considered as an “immune privileged” site, which are able to tolerate foreign antigens without causing an inflammatory immune response [22].”
Enhanced immune responses to vaccine antigens in the corneal stroma
Xia, D., Toy, R., Pradhan, P., Hejri, A., Chae, J. J., Grossniklaus, H. E., Cursiefen, C., Roy, K., & Prausnitz, M. R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.045 · Cited by 10
Dace, D. S., Chen, P. W., ALIZADEH, H. M., & Niederkorn, J. Y. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806489 · Cited by 12
“However, seminal studies performed over the past 30 years by Streilein [3] have provided important insights and have demonstrated that immune privilege is the product of multiple anatomical, physiological, and immunoregulatory processes [4].”
BackgroundKrzyżowska, M., Polanczyk, M. J., Bas, M., Cymerys, J., Schollenberger, A., Chiodi, F., & Niemiałtowski, M. (2005) · Journal of General Virology · doi:10.1099/vir.0.80709-0 · Cited by 9
“In the ocular environment, especially in tissues of the visual axis (corneal stroma, anterior chamber and subretinal space) there is an absolute requirement for clarity, and therefore any cellular infiltration is considered harmful (Streilein, 2003).”
BackgroundPark, C. Y., Yang, S., Chuck, R. S. H., Gehlbach, P. L., & Park, C. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273940903326203 · Cited by 10
Sur les origines inflammatoires de la DMLA
Roubeix, C., Sahel, J., Guillonneau, X., Delarasse, C., & Sennlaub, F. (2020) · médecine/sciences · doi:10.1051/medsci/2020159 · Cited by 20
Human iris pigment epithelial cells suppress T-cell activation via direct cell contact
Hattori, T., Kezuka, T., Usui, Y., Okunuki, Y., Takeuchi, M., Maruyama, K., Haneda, M., Shirato, S., & Gotô, H. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.04.004 · Cited by 10
“…features, suggesting that this layer of cells contributes to ocular immune privilege (Carron et al., 2000; Griffith et al., 1995; Knisely et al., 1991; Liversidge et al., 1993; Miyajima-Uchida et al., 2000; Streilein and Bradley, 1991; Sugita and Streilein, 2003; Tanihara et al., 1993).”
BackgroundInfluentialInherited retinal disease-associated uveitis
Hung, J., Jain, T., Khatri, A., Nguyen, T. T., Nguyen, C. D.-T., Yavari, N., Mobasserian, A., Karaca, I., Mohammadi, S. S., Gupta, A., et al. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.03.011 · Cited by 10
Sekulic, A., Herr, S. M., Mulfaul, K., Pompös, I.-M., Winkler, S., Dietrich, C., Obermayer, B., Mullins, R. F., Conrad, T., Zipfel, P. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03499-z · Cited by 10
Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?
Shalaby, K. E., & Abdelalim, E. M. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00786-8 · Cited by 12
“…vascularization to ensure rapid and adequate blood and oxygen supply, and nutrient exchange for islet survival and function [177–179]; innervation to modulate and control islet function [180, 181]; immune privilege to protect the islets [182]; and proximity to the liver for insulin delivery [183].”
Niederkorn, J. Y. (2005) · The Ocular Surface · doi:10.1016/s1542-0124(12)70245-8 · Cited by 8
Rajabi, F., Amoli, M. M., ROBATI, R. M., Almasi‐Nasrabadi, M., & Jabalameli, N. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01934-9 · Cited by 8
Mechanisms of immune regulation and transplantation immunity in corneal transplants
Neroev, V. V., Balatskaya, N. V., Chentsova, E. V., & Shamkhalova, K. M. (2020) · Medical Immunology (Russia) · doi:10.15789/1563-0625-moi-1768 · Cited by 9
Yao, Y., Song, Q., Zhang, J., Wen, Y., & Dou, X. (2024) · Eye and Brain · doi:10.2147/eb.s454977 · Cited by 8
“23,24 The permeability of the blood-retinal barrier and blood-brain barrier increases under hypoxia-ischemia, ultimately leading to impaired barrier function and tissue edema.”
BackgroundLi, Y., Cheng, T., Zhou, S., Li, F., Guo, W., Li, M., & Liu, T. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-03961-9 · Cited by 11
“AH is a transparent intraocular fluid that maintains the metabolic processes of intraocular tissues and the normal homeostatic environment of the eye [33].”
Effects of ambient particulate matter on a reconstructed human corneal epithelium model
Ko, R., Hayashi, M., Tanaka, M., Okuda, T., Nishita‐Hara, C., Ozaki, H., & Uchio, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-82971-1 · Cited by 10
Niederkorn, J. Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00029-6 · Cited by 9
Zhang, W., Schönberg, A., Bassett, F., Hadrian, K., Hos, D., Becker, M., Bock, F., & Cursiefen, C. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.13.18 · Cited by 8
“(2) All disease models studied here were characterized by a parallel ingrowth of BVs and LVs into the cornea, except the incision model which induced isolated LA.”
BackgroundXia, F., Yu, S., Peng, Y., Huang, B., Kang, M. C., Xiong, J., Luo, T., Wu, R., & Shao, Y. (2023) · BioMed Research International · doi:10.1155/2023/1805938 · Cited by 8
“[9, 10] This structure appears to provide protection from SSc-related vasculopathy and fibrosis processes.”
BackgroundRetractedMechanisms of corneal neovascularization and modern options for its suppression
Mamikonyan, V. R., Pivin, E. A., & Krakhmaleva, D. A. (2016) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2016132481-87 · Cited by 9
The Impact of the Eye in Dementia: The Eye and its Role in Diagnosis and Follow‐up
Salobrar‐García, E., Ramirez, A. I., de Hoz, R., Rojas, P., Salazar, J. J., Rojas, B., Yubero, R., Gil, P., Triviño, A., & Ramirez, J. M. (2016) · InTech eBooks · doi:10.5772/64490 · Cited by 12
“The eyeball is made up of some unique physical structures and contains a set of surface molecules and cytokines responsible of some specialised immune responses, similar to those observed in the brain and the spinal cord [130, 131].”
BackgroundJager, M. J., & Bronkhorst, I. H. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-40489-4_5 · Cited by 8
Tian, Z., Liu, Q., Lin, H.-Y., Zhu, Y.-R., Ling, L., Sung, T., Wang, T., Li, W., Gao, M., Cheng, S., et al. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbae091 · Cited by 8
“Additionally, the eye is considered an immunologically privileged site due to its physical structure and immune system characteristics [16].”
Targeting ocular malignancies using a novel light-activated virus-like drug conjugate
Ma, S., Veld, R. V. H. I. ‘., Pinos, E. D. L., OSSENDORP, F. A., & Jager, M. J. (2024) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2024.12.001 · Cited by 9
The Immunopathogenesis of uveitis
Han, J., Harper, J., Copland, D. A., & Maghsoudlou, P. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1717056 · Cited by 13
“Tolerogenic APCs, conditioned by the immunosuppressive ocular microenvironment, drive non-inflammatory adaptive responses and can induce ACAID, wherein ocular APCs promote antigen-specific Tregs that suppress both Th1-and Th17-mediated inflammatory responses while maintaining immune privilege (144).”
The spleen's role in transplantation immunology
Hara, M., Chosa, E., & Onitsuka, T. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.09.003 · Cited by 7
McDonald, T., Muhammad, F., Peters, K., & Lee, D. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742154 · Cited by 7
Küçük, M. F., Yaprak, L., Erol, M. K., Ayan, A., & Kök, M. (2021) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2021.06.009 · Cited by 7
Ma, S., Veld, R. V. H. I. ‘., Hao, Y., Gu, Z., Rich, C. C., Gelmi, M. C., Mulder, A. A., van Veelen, P. A., Vu, T. H. K., van Hall, T., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.42 · Cited by 7
“24,25 The virus-like drug conjugate (VDC) Bel-sar (previously known as AU-011) is being used for the treatment of UM and indeterminate choroidal pigmented lesions 26–28 (Clin-icalTrials.gov: NCT02422979).”
Innate and Adaptive Immunity of the Eye
Nissen, M. H., & Röpke, C. (2005) · Advances in organ biology · doi:10.1016/s1569-2590(05)10011-1 · Cited by 7
Hypothesis of immune privilege of the cornea and pathophysiology of graft rejection
Trufanov, S. V., Суббот, А. М., Malozhen, S. A., & Krakhmaleva, D. A. (2016) · Russian Annals of Ophthalmology · doi:10.17116/oftalma20161325117-124 · Cited by 9
“Аллоантигены, оказавшиеся в передней камере, индуцируют уникальный спектр системной иммунной реакции, кульминацией которой становится подавление антиген-специфической гиперчувствительности замедленного типа (ГчЗТ) [20, 21].”
InfluentialNeue adjuvante Therapien beim okulären Melanom
Bosch, J. J., & Heindl, L. M. (2017) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-0043-107807 · Cited by 7
Yoshitake, T., Murakami, T., Yoshitake, S., Suzuma, K., Dodo, Y., Fujimoto, M., & Tsujikawa, A. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26209 · Cited by 7
Zebrafish are Resistant to Staphylococcus aureus Endophthalmitis
Mei, F., Rolain, M. M., Zhou, X. Y., Singh, P. K., Thummel, R., & Kumar, A. (2019) · Pathogens · doi:10.3390/pathogens8040207 · Cited by 7
“However, the eye, being an immune-privileged site, provides an immunosuppressive environment for the growth and proliferation of microbial pathogens [8].”
BackgroundReprogramming the Immune System Using Antibodies
Graça, L., & Waldmann, H. (2006) · Humana Press eBooks · doi:10.1385/1-59745-049-9:247 · Cited by 7
Tissue resident memory T cells populate the human uveal tract
Foers, A. D., Reekie, I. R., Wickramasinghe, L. C., Ward, A., Buckley, T. M. W., Attar, M., Aguilar-Munoa, S., Pilapil, Q., Elsayed, M. E. A. A., Pledger, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-025-33444-2 · Cited by 8
Liu, Z., Liu, K., Shi, S., Chen, X., Gu, X., Wang, W., Mao, K., Yibulayi, R., Wu, W., Zeng, L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.175479 · Cited by 9
“The ocular environment is traditionally defined as an immune privilege site due to its immunological ignorance, induction of systemic tolerance, and regional immune suppression (31).”
BackgroundSun, Z., Ji, H., Zhou, Y., Duan, H., Ma, B., & Qi, H. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904146 · Cited by 6
Spelta, S., Micera, A., Gaudenzi, D., Niutta, M., Surico, P. L., Vincentis, A. D., Coassin, M., & Zazzo, A. D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123431 · Cited by 6
“Corneal transplantation is the most successful tissue transplantation procedure performed in humans [1,2].”
BackgroundLi, M., Wang, Y., Gao, H., Xia, Z., Zeng, C., Huang, K., Zhu, Z., Lu, J., Chen, Q., Ke, X., et al. (2024) · Autism Research · doi:10.1002/aur.3204 · Cited by 9
“The retina shows similarities to the brain and spinal cord in terms of embryology, anatomy, physiology, and histopathology (Kaur et al., 2008; London et al., 2013; Rasmussen et al., 2020; Streilein, 2003).”
Wang, Q. K., Xu, X., Chen, S., Lu, R., Li, L., Lo, C., Liu, Z., Ning, K., Li, T., Kowal, T. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn7540 · Cited by 10
“Retinitis pigmentosa (RP) is a group of inherited retinal diseases in which progressive degeneration of photoreceptor cells results in irreversible blindness ( 1 – 5 ).”
Modeling the Mechanical Parameters of Glaucoma
Vroemen, P., Gorgels, T. G. M. F., Webers, C. A. B., & de Boer, J. (2019) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0044 · Cited by 7
“Furthermore, the eye is a relatively immuneisolated organ due to the blood-retina barrier and its immunosuppressive microenvironment, resulting in better opportunities for tissue/cell transplants and stem cell therapy.(32) Current in vitro models to study glaucoma have their limitations.”
Transgenic Mice Overexpressing PG1 Display Corneal Opacity and Severe Inflammation in the Eye
Choi, M., Le, M. T., Cho, H. S., Lee, J., Jeon, H., Cha, S.-Y., Na, M., Chun, T., Kim, J., Song, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041586 · Cited by 7
“However, the eyes are immune-privileged organs that limit the entry of immune cells [32].”
BackgroundPathogenesis of Bacterial Uveitis
Wildner, G., Bansal, R., Ayyadurai, N., THURAU, S. R., & Basu, S. (2023) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2022.2155842 · Cited by 6
“10 Nevertheless, the inner eye can be severely affected by pathogens like bacteria and fungi, which are usually introduced via surgery or penetrating injury, inducing endophthalmitis.”
BackgroundToxoplasma gondii Pneumonia in an Immunocompetent Individual
Shen, C., Zhang, G., Song, X., Xie, S., & Wang, C. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000496 · Cited by 6
“The immune system of an immunocompetent host then generates an immune response, and the infection is controlled.(6) In immunodeficient individuals, the tachyzoites may continue to replicate.”
BackgroundAntigen-induced suppressor T cells from the skin point of view
Bynoe, M. S., & Viret, C. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.004 · Cited by 6
Schiffelers, R. M., van der Vaart, T. K., & Storm, G. (2011) · BioDrugs · doi:10.2165/11589330-000000000-00000 · Cited by 6
“Furthermore, the eye is an immune-privileged organ, which reduces the chances of inflammatory adverse effects.([132]) Both proteins (in particular, antibodies) and nucleic acids can be immune activators, but since distortion of the visual axis by an inflammatory process could be fatal for vision, inflammatory cascades…”
BackgroundMcVey, D., Hamilton, M. M., Hsu, C., King, C. R., Brough, D. E., & Wei, L. L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.124 · Cited by 6
McKenna, K. C., Anderson, K. M., & Kapp, J. A. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590933520 · Cited by 6
Wang, Y., Yang, P., Li, B., Zhou, H., Huang, X., Wang, Y., Chi, W., Zhu, X., Zhu, L., & Kijlstra, A. (2006) · Ocular Immunology and Inflammation · doi:10.1080/09273940600693640 · Cited by 6
Mercado-Sesma, A. R., Contreras-Rubio, A. Y., Baiza-Durán, L. M., Olvera‐Montaño, O., Miranda-Robles, M., & Bonilla-García, J. (2017) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-017-0127-2 · Cited by 6
“Background Despite of the eye having immune privilege [1, 2] exist a lot of situations where an inflammatory response can be ignited.”
BackgroundRamos, M. F., Teixeira, L. B. C., Brandt, C. R., & Auyeung-Kim, D. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_14 · Cited by 6
Uveitis and psychological stress.
Khanfer, R., Wallace, G. R., Keane, P. A., & Phillips, A. C. (2012) · PubMed · Cited by 9
MODERN OPPORTUNITIES IN UVEITIS TREATMENT
Krakhmaleva, D. A., Pivin, E. A., Trufanov, S. V., & Malozhen, S. A. (2017) · Ophthalmology in Russia · doi:10.18008/1816-5095-2017-2-113-119 · Cited by 6
A Privileged View of NKT Cells and Peripheral Tolerance Through the Eye
Stein‐Streilein, J. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940490912371 · Cited by 6
Immunologically Privileged Environments
Hedger, M. P. (2007) · Elsevier eBooks · doi:10.1016/b978-012369415-7/50031-4 · Cited by 8
Advances in eye-brain axis: Anatomy, immunity, and association with visual dysfunction
Zhang, S., Fan, Z., & Ji, D. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102925 · Cited by 7
Fanelli, G., Romano, M., Lombardi, G., & Sacks, S. H. (2023) · Cells · doi:10.3390/cells12131805 · Cited by 5
“The definition of the eye as an immune-privileged site has evolved from a concept of a passive physical barrier to a dynamic process in which intraocular inflammation is modulated by regulatory molecules and cells in the eye [4,5].”
BackgroundThe ocular immunological alterations in the process of high-risk corneal transplantation rejection
Chi, H., Wei, C., Li, M., Yu, Y., Zhang, T., & Shi, W. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109971 · Cited by 6
The adaptive immune system in the retina of diabetics
Lei, Y., Wang, Y., Tang, S., Yang, J., Lai, D., & Qiu, Q. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.11.005 · Cited by 6
Safety Evaluation of Ocular Drugs
Ramos, M. F., Attar, M., Seals, J. R., & Luhrs, K. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85704-8.00031-1 · Cited by 6
Li, Q., Jiao, W., Li, X., & Liang, L. (2025) · Reviews in Medical Virology · doi:10.1002/rmv.70056 · Cited by 5
IMMUNITY OF EYE-BULBE AND CONJUNCTIVE MICROFLORA
Кочергин, С. А., Мэлсовна, Ч. Г., Klescheva, E. A., Михайловна, Ш. И., & Mezentseva, M. V. (2014) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2012-3-635-644 · Cited by 5
Coursey, T. G., Chen, P. W., & Niederkorn, J. Y. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312122 · Cited by 5
“The AqH contains a number of anti-inflammatory and immunosuppressive factors, such as TGF- , -MSH, and VIP, which serve to quench inflammation [2–4].”
BackgroundCoursey, T. G., Chen, P. W., & Niederkorn, J. Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100826 · Cited by 5
Ligocki, A. J., & Niederkorn, J. Y. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18786 · Cited by 6
Clinical Features of Systemic Metastatic Retinal Lymphoma in Japanese Patients
Taki, R., Takeda, A., Yoshikawa, H., Fukuhara, T., Arita, R., Suehiro, Y., Choi, I., Kumano, Y., Nakamura, T., & Ishibashi, T. (2016) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2016.1151894 · Cited by 5
“The eye, as well as the testis and brain, are regarded as immune-privileged sites, which can sequester antigens from immune systems to tolerate the introduction of antigens; they possess strong blood–tissue barriers, including blood–retina barrier, blood–testis barrier, or blood–brain barrier, respectively.(20) Theref…”
BackgroundThe anterior chamber of the eye as a site for pancreatic islet transplantation
Park, S., & Lee, D. Y. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.02.027 · Cited by 5
Intracameral Microimaging of Maturation of Human iPSC Derivatives into Islet Endocrine Cells
Zhao, K., Shi, Y., Yu, J., Yu, L., Mael, A. A., Li, Y., Kolton, A., Joyce, T., Odorico, J., Berggren, P., et al. (2022) · Cell Transplantation · doi:10.1177/09636897211066508 · Cited by 4
COVID-19 vaccination and corneal allograft rejection- a review
Allen, N. E., Zhang, J., & McGhee, C. N. J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1307655 · Cited by 6
“Solid organ rejection is cell and antibody-mediated whilst tissue rejection is purely cell-mediated, however, the prevalence of both in relation to COVID-19 vaccination suggests an underlying alteration to systemic immunogenicity (Streilein, 2003; Yin, 2021).”
BackgroundZhang, T., Li, Z., Liu, T., Li, S., Gao, H., Wei, C., & Shi, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196571 · Cited by 5
Molins, B., Mesquida, M., & Adán, A. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101097 · Cited by 6
RetractedChi, H., Ma, L., Zeng, F., Wang, X., Peng, P., Bai, X., Zhang, T., Yin, W., Yu, Y., Yang, L., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.2.15 · Cited by 5
“To investigate the effect of transplantation stress–induced senescence on allograft rejection, the senolytic drug ABT-263 (50 mg/kg; Selleck Chemicals, Houston, TX, USA) 24 or vehicle was administered intraperitoneally on postoperative days 2, 4, 6, 8, 10, and 12.”
Ozaki, A., Sugita, S., Ishida, M., Nishida, M., Iseki, K., Sakai, N., Hayashi, N., Shiina, T., Yokota, S., Ito, S.-I., et al. (2025) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.66.6.53 · Cited by 4
Huang, D., Xuan, W., & Li, Z. (2025) · Viruses · doi:10.3390/v17010068 · Cited by 7
“Finally, despite its robust local defense mechanisms, the eye is considered an immune-privileged organ, meaning it possesses specialized immune-regulatory processes that minimize detrimental inflammation and protect visual function [77,78].”
Capturing Degeneracy in the Immune System
Tieri, P., Castellani, G., Remondini, D., Valensin, S., Loroni, J., Salvioli, S., & Franceschi, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-39241-7_7 · Cited by 9
Environmental Microbes and Uveitis: Is Microbial Exposure Always Bad?
Massilamany, C., Gangaplara, A., & Reddy, J. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12297 · Cited by 4
Retinal regeneration with iPS cells – Clinical trials for retinal degenerative disorders
SUGITA, S. (2015) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.38.79 · Cited by 4
Kono, D. H., & Theofilopoulos, A. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00019-x · Cited by 5
Okumura, N., Velumani, T., Pattan, H. F., Padmanaban, V., Komori, Y., Hanada, N., Hirono, T., Srinivas, S. P., Koizumi, N., & Padmanabhan, P. (2021) · Cornea · doi:10.1097/ico.0000000000002706 · Cited by 4
Farooq, S. M., & Ashour, H. M. (2021) · Cells · doi:10.3390/cells10040870 · Cited by 5
“Antigen-specific regulatory T cells (Tregs) help maintain immune tolerance through ACAID [1,2].”
BackgroundDelivery of Genetic Information: Viral Vector and Nonviral Vector Gene Therapies
Gemayel, M. C., Byrne, L. C., Ciulla, T. A., & Sahel, J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000360 · Cited by 5
DNA- and RNA-based Gene Therapies in Ophthalmology
Ciulla, T. A., Pennesi, M. E., Kiss, S., & Cunningham, E. T. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000359 · Cited by 4
Application Prospects for Synthetic Nanoparticles in Optogenetic Retinal Prosthetics
Rotov, A. Y., Romanov, I. S., Tarakanchikova, Y. V., & Astakhova, L. A. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021060132 · Cited by 4
“Following sys temic injection, nanoparticles encounter with the blood retinal barrier formed by tight junctions between endothelial cells of retinal vessels and cells of the pigment epithelium [9].”
MethodComplement Mediators in Development to Treat Age-Related Macular Degeneration
Nebbioso, M., Franzone, F., Lambìase, A., Taurone, S., Artico, M., Gharbiya, M., Greco, A., & Polimeni, A. (2022) · Drugs & Aging · doi:10.1007/s40266-021-00914-x · Cited by 5
“It has long been known that the eye is characterized by a phenomenon named “immune privilege”, which means that, at this level, inflammatory and immune reactions are limited to maintain normal function [34].”
Background
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.